MENU
+Compare
PNPL
Stock ticker: OTC
AS OF
Dec 16 closing price
Price
$0.13
Change
-$0.00 (-0.00%)
Capitalization
9.5M

PNPL stock forecast, quote, news & analysis

Pineapple Inc procures and leases properties to licensed cannabis operators, provides nationwide hemp-derived CBD sales THROUGH online and in-store transactions, and offers cannabis business licensing and consulting services... Show more

PNPL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for PNPL with price predictions
Dec 24, 2025

PNPL in +18.18% Uptrend, advancing for three consecutive days on December 15, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where PNPL advanced for three days, in of 11 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 01, 2025. You may want to consider a long position or call options on PNPL as a result. In of 62 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PNPL just turned positive on December 03, 2025. Looking at past instances where PNPL's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

PNPL moved above its 50-day moving average on December 15, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for PNPL crossed bullishly above the 50-day moving average on December 16, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PNPL moved out of overbought territory on December 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

PNPL broke above its upper Bollinger Band on December 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PNPL entered a downward trend on December 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PNPL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PNPL's P/B Ratio (0.000) is slightly lower than the industry average of (3.052). P/E Ratio (0.000) is within average values for comparable stocks, (41.387). PNPL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.138). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. PNPL's P/S Ratio (60.606) is slightly higher than the industry average of (11.390).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PNPL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 3.42B. The market cap for tickers in the group ranges from 3.29K to 24.06B. JDHIF holds the highest valuation in this group at 24.06B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was 7%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was 10%. PMHS experienced the highest price growth at 153%, while WGRX experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was -67%. For the same stocks of the Industry, the average monthly volume growth was -50% and the average quarterly volume growth was -19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 75
Price Growth Rating: 59
SMR Rating: 76
Profit Risk Rating: 96
Seasonality Score: 6 (-100 ... +100)
View a ticker or compare two or three
PNPL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry DrugstoreChains

Profile
Fundamentals
Details
Industry
N/A
Address
10351 Santa Monica Boulevard
Phone
+1 877 310-7675
Employees
N/A
Web
https://pineappleinc.com